Literature DB >> 11606464

Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes.

Y Guz1, I Nasir, G Teitelman.   

Abstract

We previously reported that new beta cells differentiated in pancreatic islets of mice in which diabetes was produced by injection of a high dose of the beta cell toxin streptozotocin (SZ), which produces hyperglycemia due to rapid and massive beta cell death. After SZ-mediated elimination of existing beta cells, a population of insulin containing cells reappeared in islets. However, the number of new beta cells was small, and the animals remained severely hyperglycemic. In the present study, we tested whether restoration of normoglycemia by exogenous administered insulin would enhance beta cell differentiation and maturation. We found that beta cell regeneration improved in SZ-treated mice animals that rapidly attained normoglycemia following insulin administration because the number of beta cells per islet reached near 40% of control values during the first week after restoration of normoglycemia. Two presumptive precursor cell types appeared in regenerating islets. One expressed the glucose transporter-2 (Glut-2), and the other cell type coexpressed insulin and somatostatin. These cells probably generated the monospecific cells containing insulin that repopulated the islets. We conclude that beta cell neogenesis occurred in adult islets and that the outcome of this process was regulated by the insulin-mediated normalization of circulating blood glucose levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606464     DOI: 10.1210/endo.142.11.8501

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  62 in total

1.  Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.

Authors:  Zhen Li; Hong-Ya Zhang; Lu-Xian Lv; Dong-Fei Li; Jing-Xing Dai; Ou Sha; Wen-Qiang Li; Yu Bai; Lin Yuan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.

Authors:  Meixia Dan; Janet K Chantler
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 3.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration.

Authors:  Cheng-Ho Chung; Fred Levine
Journal:  Rev Diabet Stud       Date:  2010-08-10

5.  Novel systems for in vivo monitoring and microenvironmental investigations of diabetic neuropathy in a murine model.

Authors:  Sharon Amit; Avraham Yaron
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

Review 6.  Development of the endocrine pancreas.

Authors:  David J Hill
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

7.  The application of umbilical cord blood cells in the treatment of diabetes mellitus.

Authors:  Tomas Koblas; S Mitchell Harman; Frantisek Saudek
Journal:  Rev Diabet Stud       Date:  2006-02-10

8.  Pancreatic endocrine and exocrine cell ontogeny from renal capsule transplanted embryonic stem cells in streptozocin-injured mice.

Authors:  Maho Kodama; Fumitaka Takeshita; Shiro Kanegasaki; Takahiro Ochiya; Gary Quinn
Journal:  J Histochem Cytochem       Date:  2007-09-17       Impact factor: 2.479

Review 9.  Stem cells, a two-edged sword: risks and potentials of regenerative medicine.

Authors:  Anna-Chiara Piscaglia
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

10.  Precursor cells in mouse islets generate new beta-cells in vivo during aging and after islet injury.

Authors:  H Liu; Y Guz; M H Kedees; J Winkler; G Teitelman
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.